Requirements for transitioning a new robotic needle-guide from biopsy to therapy applications

前列腺癌是工业化国家最常见的男性癌症。伴随着巨大的先进 在成像方面，特别是磁共振成像(MRI)，多参数MRI现在能够实现更多 准确定位前列腺癌区域，开拓新的治疗可能性。其中之一 它们是前列腺局灶性疗法，它只存在于治疗癌症确认区(S)范围内 前列腺。这种方法有望减少毒性并提高生活质量。目前的建议是 涉及一种新的生物医学技术，能够使用机器人进行准确的、实时的MRI引导的活检 由魁北克舍布鲁克的Polmer Robotics开发的针导轨。这个装置是独一无二的，它的提议 研究打算评估该设备还执行基于针的治疗的能力，例如(但不是 仅限于)近距离放射治疗、冷冻治疗和许多其他。目前在世界上还没有这样的机器人设备 可以在实时核磁共振下执行诊断程序(活检)和治疗程序的市场。

Prostate cancer is the most common cancer in men in industrialized countries. With the tremendous advanced in imaging, in particular magnetic resonance imaging (MRI), multi-parametric MRI is now enabling more accurate localization of cancerous regions within the prostate and opens-up new treatment possibilities. One of them is prostate focal therapy, which consist in the treatment of only the cancer proven zone(s) within the prostate. This approach is expected to lead to reduce toxicity and better quality of life. The present proposal is related to a new biomedical technology enabling accurate, real-time MRI-guided biopsy taking using a robotic needle guide developed by Polymer Robotics from Sherbrooke, Quebec. This device is unique and the propose research intends to evaluate the capacity of the device to also perform needle-based therapy such as (but not limited to) brachytherapy, cryotherapy and many others. There is currently no such robotic device on the market that can perform both diagnostic procedures (biopsy) and therapy procedures under real-time MRI.